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Abstract  
 
Master Thesis/Degree project 
Clinical outcomes of punch-grafting for chronic leg and foot ulcers – A retrospective case 
series study 
Programme in Medicine 
Lisa Groening, 2015 
The Department of Dermatology and Venereology, Gothenburg, Sweden  
Introduction 
Punch-grafting has been used at The Department of Dermatology since the mid 1990´s for 
hard to heal ulcers of the leg and foot. These medical conditions are rather common, 
especially in the elderly population, and the prevalence is expected to increase due to longer 
life expectancy. Therefore evaluating this treatment method is necessary, something that has 
not been completely done before.  
Aim 
The aim of this study was to evaluate the clinical outcome of punch-grafting as a treatment for 
hard to heal leg and foot ulcers. 
Methods 
A single-center retrospective case-series study was performed to investigate the frequency of 
complete wound closures within 3 and 12 months after treatment. Data on case-subjects were 
collected manually from patient charts at Sahlgrenska University Hospital, primary care 
facilities or other forms of health care providers in charge of follow-up. Patients treated with 
punch-graft for one or several leg or foot ulcers at the Department of Dermatology between 
January 2004 and September 2013 were included in the case-group. 
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Results 
A total of 213 patients with 284 ulcers were included and the mean age was 73.2 ±13.6 years. 
At 3 months 18.7 % of the ulcers had healed and at 12 months 52.2 %. Mean time to healing 
was 136 days for all ulcers that healed and mean ulcer duration prior to punch-graft was 25 
months. Analysis of possible correlation between ulcer duration before punch-graft and time 
to healing, patient age and time to healing and localization of the ulcer and time to healing 
had no significant result. 
Conclusions/Implications 
The healing rates in this study were somewhat lower than those in previous studies made on 
pinch-and punch-graft. Ulcers categorized as ”others” had the shortest time to healing, 
indicating that these might be the most suitable ulcers for punch-graft.  Even so, it is hard 
making any conclusions regarding these results due to the study design and further research is 
required before determining the future of this treatment method.   
Key words  
Chronic ulcer, Foot ulcer, Leg ulcer, Skin transplantation, Wound healing 
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Background 
	  
Introduction 
The definition of chronic wounds is wounds that despite a timely and orderly reparative 
process for production of anatomical and functional integrity still fail to proceed during a 3-
month period (1). European studies have shown point prevalence for open leg ulcers to be 1-4 
per 1000 inhabitants (2-4). Urban populations in Sweden have been studied in two different 
Swedish studies resulting in a prevalence of 0.12 % regarding leg and foot ulcers (5, 6). Leg 
ulcers appear to be more common in the elderly population and about 60 % of the patients 
have turned 50 before they develop their first ulcer. Moreover, at an age over 85, 15-25 per 
1000 individuals suffer from open ulcers (7).  The aethiology is venous disease for many of 
these ulcers (8) and most venous ulcers are caused by a long duration of venous hypertension 
together with insufficiency. This does not only result in high costs for society but also in 
several negative effects on quality of life for each patient (9, 10).  
 
In Sweden, an estimated calculation of the annual wound management costs was SEK 2.3 
billion during the year of 1992 (11). In a study made by Phillips et al. 81 % out of 73 patients 
with chronic leg ulcers believed their ulcer had a great negative impact on their mobility. 
Moreover, they found a connection between the amount of time spent on the ulcer care and 
emotions like resentment and anger (12). Regardless of the aethiology of a leg ulcer, there is a 
risk of developing severe pain (13). For some patients, the pain makes a great impact on their 
daily life spending an average of 1.5 to 2 hours a day well-aware of their ulcer (14).  
 
Classifications of chronic leg and foot ulcers  
A ulcer located to the leg is not equivalent with a diagnosis, instead it should be considered as 
a sign of another underlying disease (15). In order to determine an adequate treatment, a 
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working diagnosis is of high clinical value (16).  
The aethiology of chronic leg ulcers varies. In a study made by Callam et al. the cause of leg 
ulcers was determined in a general population. They studied 600 out of 1447 leg ulcer patients 
in a population of about a million Scottish inhabitants. When investigating aethiological 
factors of these leg and foot ulcers they found venous disease as a factor in 76% of the cases, 
arterial insufficiency in 22%, rheumatoid arthritis in 9% and diabetes in 5% of the patients 
(17). Moreover aethiologies in excess of these also existed but in a smaller quantity and also 
several ulcers had a multifactorial origin and did therefore not fit into any specific group.  
 
Venous aethiology  
It has been estimated that 1 % of the population will suffer from chronic leg ulceration at 
some point in life (18) and in a study made by Nelzén et al. 54 % out of 382 patients with 
active chronic leg ulcers suffered primarily from a venous disease (8).  When diagnosing 
venous insufficiency it is almost always enough to study the skin searching for specific signs 
i.e. oedema, hyperkeratosis, hyperpigmentation, lipodermatosclerosis and atrophie blanche 
(19). In general, a long duration of venous hypertension together with insufficiency causes 
venous ulcers. These in turn are effects due to reflux because of incompetent valves which 
can be due to previous venous thrombosis (19).  
 
In a population study made by Fowkes et al. no obvious risk factors for venous reflux 
according to life style was found. However, they found that some factors might play a role. 
For women, these factors were previous pregnancy, lower intake of oral contraceptives, 
overweight and amount of movement at work. For men body height was a factor (20).   
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An important aspect of venous disease is the effect on quality of life for each patient. This 
condition is both time consuming due to frequent consultations and nursing but also regarding 
the number of days away from work and in some cases even unemployment (21).    
Regarding venous ulcers and adverse effects pain is one of the most frequently reported (22) 
and in an integrative review including 22 studies, Gonzalez-Consuegra et al. found that the 
most common factor affecting health-related quality of life was pain (23). Furthermore, ulcers 
causing severe pain are known to not heal (24). Besides great impact on the individual, these 
ulcers also have economic aspects. In developed countries, chronic leg ulceration accounts for 
approximately 1 % of the total cost for health care (25).  
 
There are more women than men suffering from venous stasis ulcers and the incidence, 
regardless sex, increases with age (26). The different types of leg ulcers have, in most cases, 
characteristic localizations. Above the malleoli, in the ankle area, venous leg ulcers usually 
occur (27). When studying a venous ulcer it has characteristic borders with irregular shape 
and is badly defined. Furthermore, the bed of the wound is usually shallow and they mostly 
have a larger area than other types of chronic wounds, sometimes localized to the extremity 
circumferentially (28).  
 
Arterial aethiology 
About 25 % of leg ulcer patients suffer from arterial disease. Callam et al. showed similar 
data in a study were 21 % out of 600 patients with leg ulceration had an arterial disease (29). 
The cause of arterial leg ulcers is arterial occlusion leading to local hypoxia. The most 
common pathology behind this occlusion of leg arteries is peripheral arterial occlusive disease 
(PAOD) (30). Moreover, arterial ulceration can be caused by diabetes, vasculitis, thalassemia, 
pyoderma gangrenosum and sickle cell disease. Risk factors regarding peripheral vascular 
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disease that can be modified include hypertension, hyperlipidemia, smoking, diabetes, obesity 
and lack of exercise. Some patients also have cardiovascular disease in their medical history 
such as angina pectoris, myocardial infarction, stroke and/or intermittent claudication (31).   
 
Arterial ulcerations are often localized to the toes, heels and other protruding bony parts of the 
foot. Usually they have a round shape together with a distinct border and a base looking pale 
without granulation and in most cases necrosis occur. Oftentimes the ulcer is extremely 
painful, even at rest (31).  During clinical examination cold feet, weak pulses when palpating 
dorsalis pedis arteries and extended capillary refill time in the toes indicate arterial 
insufficiency. Furthermore, examination of distal pulses with ultrasound (Doppler), arterial 
brachial index (ABPI) and toe brachial index (TBI) can verify a reduced arterial blood supply 
in the extremity (28). ABPI can be used as a measurement of the severity of the disease. 
Normally, ABPI is around 1.0 or slightly above. ABPI between 0.7-1.0 indicates mild arterial 
disease, an index between 0.5-0.7 mild to moderate and 0.3-0.5 is severe. An index of 0.3 or 
less does not only implicate severe arterial disease but also there is a risk of losing the 
extremity (31).    
 
Mixed aethiology 
Approximately 15 % of all leg ulcers constitute of combined venous and arterial disease, also 
known as mixed leg ulcers (8). A majority of these ulcers have a primary venous aethiology 
meanwhile the arterial occlusions makes the healing complicated (30). Callam et al. found 
that 176 out of 827 ulcerated legs had an arterial component. Of these 176 legs, 52 % had 
characteristic signs of chronic venous insufficiency and/or varicose veins (29).  
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Diabetes aethiology 
In a retrospective cohort study made by Ramsey et al. the yearly incidence of foot ulcers was 
2 % in a group of almost 9000 patients with diabetes mellitus type 1 or 2. Furthermore, 15.6 
% of the patients developing a foot ulcer needed amputation (32). Diabetic ulcers are most 
common over pressure points and the distal metatarsal joints are particularly exposed (33). 
Boyko et al. found several factors associated with diabetic foot ulceration such as some 
deformities of the foot, massive body weight, decreased perfusion of the foot and lowered 
skin oxygenation and also neuropathy affecting both autonomic and sensory neurons (34). 
Numerous factors are known to influence diabetes wound healing, making it delayed. These 
factors include inadequate patient compliance regarding treatment, insufficient local 
oxygenation and deficient blood sugar control (35). Diabetic foot ulcers also have an 
economic aspect, due to extended and labour-consuming health care. Hospitalization is 
frequently required for patients with diabetes and it has been noted that these visits consume 
59% more time for those diabetic patients having an ulcer than those without (36).  
 
Uncommon aethiologies 
There are also more uncommon aethiologies of hard to heal ulcers such as vasculitis and 
pyoderma gangrenosum. Although vasculitis can be described as a heterogenous group of 
conditions they have one thing in common; vessel damage due to inflammation. Based on 
clinical findings, type of infiltrate or size of the vessels a number of different subdivisions are 
possible (37).  Pyoderma gangrenosum is an ulcerating dermatosis causing ulcers that are 
deep and necrotic together with an elevated, violet border. Since the cause of pyoderma 
gangrenosum is not known, clinical findings are helpful to diagnose this condition. Different 
kinds of immunomodulatory drugs are the only alternative when treating this process and 
without treatment the ulceration proceeds (27). 
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Treatment of hard to heal ulcers of the foot and leg 
Pinch-grafting is an alternative when treating chronic foot and leg ulcers, a method that was 
first described by a surgeon named Reverdin in 1869. When harvesting the pinch-grafts, 
during local anesthesia, a scalpel and nipper are used for excision meanwhile the skin is 
elevated (38). In practice it is rather easy to perform and can easily be done in the primary 
care (39). Furthermore, it has been shown that the cost for this procedure is 3.3-5.9 times 
lower in the primary care compared with in hospital care (40).  It is not clear how skin grafts 
are able to enhance healing but it is suggested that the grafts both replace old tissue and also 
provides with essential components stimulating healing (41). In addition to pinch-grafting 
there is also punch-grafting where a biopsy punch instead of a nipper is used. However the 
excision still requires a scalpel.  Local anesthesia is enough, allowing this procedure in both 
primary and hospital care (42).  
 
The preparation of the bed of the wound plays an important role when it comes to the survival 
of the graft. The bed needs to have sufficient vascularization for the survival of the skin graft. 
Achieving this requires total loss of foreign material, devitalized tissue and biofilms. 
Therefore it is beneficial with a radical debridement before skin grafting (43). There are 
different methods regarding debridement such as enzymatic, autolytic, surgical or mechanical. 
When it comes to autolytic debridement interactive dressings are used, for example 
hydrocolloids, hydrogels and alginates (44).   
 
Several reports have described enhanced healing when pinch-grafting has been done (39, 45-
47). A report from Öien et al. showed healed ulcers in 33 % of the cases after 12 weeks (45). 
Furthermore, Christiansen et al. had similar results with 22 % healed at 8 weeks follow-up 
(47). Nevertheless, there are just a few randomized controlled trials investigating autologous 
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skin graft transplantation compared to other forms of treatment regarding hard to heal ulcers. 
One of these made by Jakunas et al. (48) comparing skin grafting with standard of care when 
treating chronic venous ulcers. The results showed that within 6 months 67.5 % of the ulcers 
being grafted were healed. At the same time none of the ulcers in the standard of care group 
had healed. In another study made by Warburg et al. skin grafting, using meshed split skin, 
was compared with standard of care in venous ulcer patients that had undergone vascular 
surgery. However, they did not find any correlation with enhanced healing (49). These two 
studies were included in a Cochrane review made by Jones et al. investigating skin grafting as 
a treatment for venous leg ulcers. In summary, neither of these studies had enough evidence to 
prioritize autologous skin graft before standard of care. Due to this result, more research is 
required for evaluation of the effects of skin grafting on ulcer healing (50).  
 
Punch-grafting has been used since the mid 1990´s at the Department of Dermatology at 
Sahlgrenska University Hospital. This method has primarily been used for ulcers where 
conservative treatment using wound dressing has been unsuccessful. During these years it has 
been practiced in both inpatient and outpatient care with the aim to promote wound healing 
and also decrease pain associated with the wound. Based on experience superficial wounds 
without extensive oozing together with a bed of granulation tissue are considered most 
suitable for punch-grafting. A clean wound without infection is necessary before punch-
grafting to ensure efficiency regarding healing. In practice, a number of viable biopsies 
consisting of autologous skin tissue are extracted with the assistance of a 4-millimeter biopsy 
punch. The donor site, usually the thigh, is locally anesthetized using lidocaine with 
epinephrine. After harvesting the grafts they are placed with at least an interspace of 4 
millimeters in the ulcer. Thereafter, paraffin gauze compresses (Jelonet, Smith&Nephew, 
Sweden) dresses the ulcer making sure the grafts are in direct contact with the bed of the 
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ulcer. On top of this dressing, another dressing (Aquacel, ConvaTec Wound Therapeutics, 
Sweden) is applied. Finally, if the arterial circulation allows it and the patient is fine with it, a 
compression bandage is used. Today it is more common using negative pressure wound 
therapy after punch-grafting due to the initial restrictions following the procedure together 
with the difficulty to optimize graft conditions for patients with self-care at home. At first it is 
important for the patient to stay as immobilized as possible and also keeping the leg elevated. 
After 3 days the inner dressing is changed for the first time. However, the outer dressing can 
be changed on a daily basis or even more often if needed. Furthermore, the wound is 
ventilated without the dressing that is on top for 20-30 minutes every day. This is how the 
nurses at the Department of Dermatology at Sahlgrenska University hospital have been 
performing the post punch treatment for over ten years (51).  
 
Dressings used for patients treated with standard of care instead of punch-grafting are in 
principle the same as the ones that are used after punch-graft. Also the basic strategy 
regarding the dressings is basically the same. However, different nurses and physicians might 
have individual prioritization. One thing that might differ between the treatment options is the 
method of debridement. Ulcers not being punched can be debrided with a pharmaceutical 
substance reminding of gel, also known as Cadoxomerejod (Iodosorb, Smith&Nephew 
Sweden). Ulcers containing punch-grafts can only be debrided by sharp debridement since 
addition of more fluid to the ulcer bed might result in the grafts not taking. When performing 
this sharp debridement with curette it is very important to be careful using a small instrument 
minimizing the risk of graft disruption. For the same reason local anesthetics, e.g. Xylocain, 
are carefully used. Therefore the debridement might be more painful for the punch-grafted 
patients sometimes resulting in a less thorough debridement (51).  
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Although punch-grafting has been used for nearly 20 years at the Department of Dermatology 
at Sahlgrenska University Hospital no guidelines have been defined for the method. Instead 
each physician has decided when to practice this method. Furthermore, no analysis has been 
made evaluating the outcome of this procedure except for one study made by Nordström and 
Hansson in 2008 (52) where 22 patients with chronic leg and foot ulcers were included and 
treated with punch-grafting resulting in 50 % ulcers healing rate at a mean of 2.5 months. 
These results were consistent with results from studies on pinch-grafting (47, 53, 54). 
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Aim  
 
The aim of the current study was to evaluate the clinical outcome of punch-grafting as a 
treatment for hard to heal leg and foot ulcers.  
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Material and Methods  
Study design 
The design of this study was a single center retrospective case series study for investigation of 
the frequency of complete wound closures within 3 and 12 months after punch-grafting. The 
data on case subjects were acquired by a manual retrospective data collection from medical 
records at Sahlgrenska University Hospital, primary care facilities and also home care 
services or other forms of health care providers in charge of follow-up.  Patients included in 
the case-group were all of them who had been treated with punch-graft for one or several 
ulcers located to the leg or foot at the Department of Dermatology at Sahlgrenska University 
Hospital during the period between January 2004 and September 2013.  For assessment of a 
12-month follow-up period copies of the included patients charts were requested from the 
respective primary care unit, homecare service or other health care providers. Thereafter 
collection of study data was made during a manually process. 
 
Study population 
Through an automated search of electronic patient charts at the Department of Dermatology at 
Sahlgrenska University Hospital on potential treatment-codes regarding punch-graft treatment 
and diagnosis codes for potential ulcers (Table 1), possible case-subjects were identified. 
Thereafter these electronic charts of potential case-subjects were analyzed during a manual 
process selecting the case-group with the exclusion and inclusion criteria in mind. Subjects 
included in this case group had clinically been diagnosed with chronic ulcers located to the 
leg or foot and had also been treated with punch-graft for at least one leg or foot ulcer at the 
Department of Dermatology between January 2004 and September 2013. Patients receiving 
this treatment more than once were only included regarding their first treatment. For 
	   	   	  
	  
16
exclusion criteria see Table 2. Altogether 213 case-subjects were included with a total of 284 
punch-grafted ulcers.  
 
Table 1. Main diagnosis codes describing ulcers potentially includable in 
the study  
 
Table 2. Exclusion criteria 
 
 
 
Data collection 
Based on the diagnosis code or notes made by the physician in the medical records an 
aethiological diagnosis was found for all the study subjects. A majority of the patients had 
been examined with a hand held Doppler resulting in an ankle blood pressure. Furthermore, 
some of the patients visited the Department of Clinical Physiology for extended examination 
regarding the arterial and venous circulation determining toe pressure and venous reflux 
respectively. In those cases where vasculitis might be the cause biopsies of the skin were send 
for further examination if the physician believed the donor site would be able to heal 
adequate.  
Main diagnosis codes describing ulcers potentially includable in the study
Diagnosis code
L979 Ulcer of lower limb, not elsewhere classified
I702C Atherosclerosis of arteries of extremities with ulceration
I830 Varicose veins of lower extremities with ulceration
I832 Varicose veins of lower extremities with both ulcer and inflammation
E10.6D Type 1 diabetes mellitus with (diabetic) foot ulcer
E11.6D Type 2 diabetes mellitus with (diabetic) foot ulcer
Exclusion criteria
Subjects before exclusion n=244
N (%)
Excluded patients 31 (12.7%)
                  Exclusion criteria 
Death within 3 months from baseline 4 (12.9%)
Follow-up data at 3 months not available 2 (6.5%)
Vascular surgery within 3 months from baseline 3 (9.7%)
Ulcer duration < 2 months 8 (25.8%)
Unknown aetiology 10 (32.3%)
Ulcer location elsewhere 2 (6.5%)
Missing baseline data 1 (3.2%)
Other 1 (3.2%)
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In this study the classifications venous, arterial, pressure, diabetic, mixed or “other” ulcers 
were used. Aethiologies of more uncommon kinds ended up in the group called “other” ulcers 
to simplify the data managing process and consisted of vasculitic ulcers, ulcers caused by 
pyoderma gangrenosum, traumatic ulcers etc. Further information such as sex, year of birth, 
location and duration of the current ulcer were gathered from the medical records. Baseline 
was set as the date of the first punch-graft transplantation.  
 
Patients with more than one ulcer treated with punch-graft had each wound registered as a 
separate case. A number of ulcers were grafted more than once; however calculation of time 
to wound closure was based on the date for the first punch-graft treatment since this was set as 
baseline.  
Evaluation of healing frequency was made after 3 and 12 months from baseline. Wounds not 
healed within this period did not have further follow-up.  
 
All ulcers that healed within 12 months had time to wound closure calculated. Regarding 
wound closure a single measurement could not be used for all the patients. Instead the 
medical records were used as guideline looking for ulcer descriptions or notes from 
physicians or nurses regarding wound healing. Description of re-epithelialization of the ulcer, 
no need for further treatment with dressings or notes saying the ulcer had healed was defined 
as complete wound closure.  
 
Data regarding history of diabetes, cardiovascular disease, vascular surgery, deep venous 
thrombosis, systolic blood pressure, ankle- and toe-pressure, body weight and height, levels of 
fasting blood glucose and HbA1c was obtained from the patient charts. Moreover the 
frequency of hospitalizations and also outpatient visits at the Department of Dermatology 
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regarding the punch-grafted ulcer within a period of 12 months from baseline was noted 
together with any arterial or venous surgery within 3-12 months after baseline. The quantity 
of antibiotic prescriptions within the first 3 months, initiation of or ongoing treatment with 
antibiotics at baseline and type/dosage of analgesic medication at baseline and 3 months 
ahead was also noted. Finally, the number of repeated punch-graft treatments for the same 
ulcer within 12 months was obtained.  
 
Statistical methods 
Fisher’s exact test was used to compare proportions between groups. Wilcoxon’s rank sum 
test was used for two-sample comparisons between groups. A Cox’ proportional hazards 
model was used with the wounds “time to healed” as the dependent variable. If the time to 
healing was more than 365 days, the time was treated as censored at 365 days. Ulcer duration 
before treatment, type of wound, patient age and localization was used as predictors. Also a 
Cox’ proportional hazard model was used for each subgroup defined by wound type with the 
same dependent variable and predictors as above (excluding wound type) and with year of 
treatment (categorized as 2004-2008 or 2009-2013) added as a predictor. All tests were two-
sided. Furthermore a p-value <0.05 was considered as statistically significant.  
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Ethics  
 
Prior to initiating this study a research protocol including description of the design and 
execution of the project was committed and send to the regional ethical review board for 
consideration. Their evaluation was that no approval of the board was necessary based on the 
fact that the study is a retrospective quality evaluation of a treatment method given by the 
Department of Dermatology at Sahlgrenska University Hospital. Furthermore Helena 
Gustafson, The Head of the Department of Dermatology, gave permission to collect data from 
the patient records. 
 
Since only the investigators together with authorized personnel being a part of the study had 
the possibility to access original data files, the confidentiality regarding study materials were 
protected. All patients were assigned with a number impossible to connect to the individual 
and the obtained data was anonymously processed with no connections between patients and 
analyzed data.  
 
Incoming data from other units than the Department of Dermatology sometimes contained 
information regarding other conditions than the wound. Due to ethical and patient related 
considerations only information essential for the study were obtained. It was taken into 
consideration the possibility of insulting patient privacy by overcoming irrelevant fact when 
carrying out the study. However, the positive effects with an evaluation of a common method 
of treatment were considered to outweigh this risk. The original copies consisting of study 
material will be safely housed according to every institutional research requirement, law and 
regulation.   
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The WMA Declaration of Helsinki states that all research including human participants 
requires informed consent. Though, §32 declare “there may be exceptional situations where 
consent would be impossible or impracticable to obtain for such research” (55). These words 
can, according to the investigators, be applied on this current study. This because of the great 
amount of patients included in this study whose medical records require a manually analysis 
for finding and including suitable subjects. Several of these candidates had already passed 
away making an informed consent impossible. In excess of this decision regarding the 
Helsinki declaration the “Lagen om etikprövning och forskning som avser människor” state in 
§20 and §21 that research is allowed without informed consent in some conditions, which 
corresponds well with this current study.  
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Results  
 
The data collection resulted in 213 patients included in the case group with a total of 284 
ulcers treated with punch-graft. The gender distribution was around 60 % women (129 of 213) 
and around 40 % (84 of 213) men. The mean age was 73.2 (±13.6) years and the number 
of patients with an age of 65 or older was almost 80 % (169 of 213) (Table 3).  
 
Table 3. Characteristics of the patients treated with punch-graft  
 
 
17.8 % of the patients (38 of 213) had diabetes, either type I or II and 15.0 % (32 of 213) had 
a history of deep venous thrombosis in the punch-grafted extremity. Furthermore, almost 30 
% of the patients had previously undergone either arterial, venous or both types of surgery in 
the affected limb (Table 4). Data regarding cardiovascular comorbidity is also presented in 
Table 4. In summary almost 60 % (124 of 213) of all cases had some kind of cardiovascular 
disease, hypertension being the most common (47.9 %) followed by myocardial infarction 
(16.0 %).  
 
 
 
 
Charactersitics of the patients treated with punch graft
Case -subjects n=213
N (%) or Mean ±SD
Sex
Female 129 (60.6%)
Male 84 (39.4%)
Age (years) 
Mean 73.2 ± 13.6
Rage 23-96
≥65 169 (79.3 %)
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Table 4. Comorbidity of the 213 case-subjects treated with punch-graft 
 
 
Table 5 presents all data collected at baseline for all of the patients included in this study. For 
example the mean number of outpatient visits was 6.5 (±9.7) during the first year from 
baseline meaning the frequency of visits, either to a physician or nurse, at the Department of 
Dermatology due to the specific ulcer. Moreover the mean number of hospitalizations because 
of the punch-grafted ulcers was 1.7 (±1.5) times during a period of 12 months from baseline. 
When calculating the mean number of analgesics at baseline each patient had approximately 5 
pills consisting of paracetamol/NSAID, non-narcotic prescriptions, narcotic prescriptions, 
transdermal analgesic patches or combinations of these. 14 patients (6.6 %) had vascular 
surgery (arterial or venous) within 3-12 months after baseline.  
 
 
 
 
 
Comorbity of the 213 case-subjects treated with punch-graft 
Case-subjects n=213
N (%)
Cardiovascular disease 124 (58.2 %)
Myocardial infarction (MI) 34 (16.0%)
Stroke 23 (10.8%)
Angina 23 (10.9%)
Hypertension 102 (47.9%)
Diabetes 38 (17.8%)
Type I 6 (2.8%)
Type II 32 (15.0%)
Previous Deep Venous Thrombosis (DVT) 32 (15.0%)
Previous Vascular surgery 62 (29.1%)
Arterial 28 (13.2%)
Venous 40 (18.8%)
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Table 5. Data at baseline for the 213 case-subjects 
 
 
 
 
Data at baseline for the 213 case-subjects
Case-subjects n=213
N (%) or Mean ±SD
Age 73.2 ± 13.6
Systolig blood pressure (mmHg) 139.8 ± 19.1
Ankle pressure (mmHg) 134.0 ± 40.9
ABPI (Ankle Brachial Pressure Index) 0.9 ± 0.3
Length (cm) 169.8 ± 9.6
Weight (kg) 77.6 ± 24.5
BMI (Body Mass Index) 27.2 ± 7.2
Fasting blood sugar (mmol/L) 5.8 ± 1.5
HbA1c (mmol/mol) 53.1 ± 15.3
Toe pressure (mmHg) 73.9 ± 33.6
Number of outpatient visits 6.5 ± 9.7
Number of hospitalizations 1.7 ± 1.5
Antibiotic prescription within 3 months 0.7 ± 0.9
Number of prescriptions
1 59 (27.7%)
2 24 (11.3%)
3 11 (5.2%)
4 3 (1.4%)
On-going antibiotic treatment at baseline 100 (46.9%)
Initiation of antibiotic treatment at baseline 3 (1.4%)
Baseline frequency of analgesics 5.1 ± 4.6
Type of analgesics 
 Paracetamol 125 (59.2 %) 
Prescription non-narcotic 24 (11.3%)
Narcotic prescriptions 84 (39.6%) 
Transdermal analgesic patches 9 (4.2%)
3 month frequency of analgesics 6.0 ± 4.7
Type of analgesics 
Paracetamol 20 (71.4%) 
Prescription non-narcotic 4 (4.0%)
Narcotic prescriptions 21 (21.2%)
Transdermal analgesic patches 0
Vascular surgery within 3-12 months 14 (6.6%)
Arterial surgery 10 (4.7%)
Venous surgery 4 (1.9%)
Siffrorna vad gäller analgesics innebär att % är antalet dividerat med alla pat som har registrerat antingen 1 eller 0 i denna kolumn, OBS de med NA registrerat har inte tagits med i beräkningarna 
baslinefrequency.analgesics.innebär.antalet.tabletter.man.tar.varje.dag,.inte.vilken.sort.det.rör.sig.om..
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About 10 % (31 of 284) of the ulcers were located to the foot and 90 % (253 of 284) to the 
leg. The distribution of ulcer type is presented in Table 6 and reveal a venous aethiology in 
almost 45 % (124 of 284) of the ulcers followed by approximately 25 % (68 of 284) mixed 
ulcers, about 20 % (56 of 284) ulcers with an "other" classification, 10 % (32 of 284) arterial 
ulcers, 1 % (4 of 284) diabetic ulcers but no pressure ulcers. The mean duration of all ulcers at 
baseline was 24.9 (±33.8) months and the mean value for each ulcer is presented in Table 6, 
venous ulcers having the longest duration before punch-graft. Overall, almost 70 % (193 of 
284) of the ulcers, regardless of aethiology, had existed for 6 months or more.  
 
Table 6. Characteristics for the 284 ulcers treated with punch-graft 
 
 
When analysing data regarding healing rate at 3 and 12 months after the punch-graft, data was 
found for 97.9 % (278 of 284) and 87.3 % (249 of 284) of the subjects.  When investigating 
the outcome at 3 months after baseline almost 20 % (52 of 284) of all ulcers were healed and 
at 12 months almost 50 % (130 of 284) had healed. The mean time to healing was 136.2 
(±89.6) days regardless aethiology. Numbers for each ulcer type are presented in Table 7.  
For more details regarding patient age and number of healed ulcers within 3 months, see 
Table 8 and 9.  
Characteristics of the 284 ulcers treated with punch-graft 
Specific ulcers n=284
N (%) or Mean ±SD
Ulcers of the foot 31 (10.9%)
Ulcers of the leg 253 (89.1%)
Venous ulcers 124 (43.7%)
Arterial ulcers 32 (11.3%)
Diabetic ulcers 4 (1.4%)
Pressure ulcers 0
Mixed ulcers 68 (23.9%)
Other ulcers 56 (19.7%)
Mean duration of ulcer presence at baseline (months) 24.9 ± 33.8
Venous ulcers 30.9 ± 37.9
Arterial ulcers 20.6 ± 23.2
Diabetic ulcers 21.0 ± 17.2
Mixed ulcers 22.2 ± 23.5
Other ulcers 18.7 ± 39.6
Duration of ulcer ≥6 months 193 (68.0%)
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When applying a Cox proportional hazards survival model there was no significant 
correlation between: ulcer duration before punch-graft and time to healing (p=0.285), age of 
the patient and time to healing (p=0.478) or location of the ulcer and time to healing 
(p=0.4776). The same statistical method was also used to investigate if there was any 
difference in time to healing between all the various types of ulcers. A significant result was 
only found for the ulcers classified as arterial (p=0.0486) and “other” (p=0.0005).  
With arterial ulcers having a mean time to healing of 151.4 ± 85.4 days (95 % Confidence 
interval 107.5-195.3) they had the second longest time to healing and a higher mean value 
than the group of all ulcers regardless type (136.2 ± 89.6 days). The group with ”other” ulcers 
had a mean time to healing of 93.8 ± 78.9 days  (95 % Confidence interval 65.8-121.8) 
meaning they had the shortest time to healing of all ulcer types and also a faster healing rate 
than the group consisting of all ulcers.   
 
Table 7. Ulcer healing with aetiological classification of the 284 ulcers  
 
 
Ulcer healing with aetiological classification of the 284 ulcers treated with punch-graft 
Specific ulcers n=284
N (%) or Mean ±SD
Healing rate at 3 months 52 (18.7%)
Venous ulcers 20 (16.3%)
Arterial ulcers 4 (13.8%)
Diabetic ulcers 1 (25.0%)
Mixed ulcers 5 (7.4%)
Other ulcers 22 (40.7%)
Healing rate at 12 months 130 (52.2%)
Venous ulcers 56 (49.1%)
Arterial ulcers 17 (73.9%)
Diabetic ulcers 2 (50.0%)
Mixed ulcers 22 (36.1%)
Other ulcers 33 (70.2%)
Mean time to healing (days) 136.2 ± 89.6
Venous ulcers 144.4 ± 92.6
Arterial ulcers 151.4 ± 85.4
Diabetic ulcers 116.5 ± 85.6
Mixed ulcers 169.3 ± 84.1
Other ulcers 93.8 ± 78.9
Healing rate för respektive sår innebär % av alla sår av den typen!
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Table 8. Ulcer healing with age of the patients 
 
 
Table 9. Ulcer healing with age of the patients  
 
 
Complications within 3 months from baseline were found in 59 patients whereof 9 patients 
had 2 complications during this period of time. In Table 10 the different types of 
complications are listed, the most common was infection involving the specific ulcer. Some 
patients underwent punch-graft more than once for the same ulcer during 12 months after 
baseline, also presented in Table 10.  
 
Table 10. Complications and adverse events for the 284 ulcers 
	  
Age Ulcers treated with punch-graft Healed ulcers at 3 months, N (%)
20-29 2 1 (50.0%)
30-39 8 2 (25.0%)
40-49 9 1 (11.1%)
50-59 17 7 (41.2%)
60-69 50 14 (28.0%)
70-79 86 15 (17.4%)
80-89 90 11 (12.2%)
90-99 16 1 (6.3%)
Age (years) Ulcers treated with punch-graft Healed ulcers at 3 months, N (%)
<60 36 11 (30.6%)
≥60 242 41 (16.9%)
<70 86 25 (29.1%)
≥70 192 27 (14.1%)
Age Ulcers treated with punch-graft Healed ulcers at 3 months, N (%)
2 2 2 1 50.
3 3 8 2 25.0
4 4 9 1 1 .1
5 5 17 7 (41.2 )
6 6 50 4 28 0
7 7 86 5 7 4
8 8 90 1 12.2%)
90-99 16 1 (6.3%)
Age (years) Ulcers treated with punch-graft Healed ulcers at 3 months, N (%)
< 36 1 30 6
≥60 242 41 (16.9%)
< 86 5 29
≥70 192 27 (14.1%)
Complications and adverse events for the 284 ulcers 
N (%)
Patients with complications within 3 months 59 (27.7%)
                                                Type of complication
Infection 55 (80.9%)
Hard to heal ulcer at donor site 2 (2.9%)
Infection at donor site 3 (4.4%)
Other 8 (11.8%)
Ulcers with repeated punch-graft treatment within 1 year 81 (28.5%)
       Treatment repeated once 62 (76.5%)
Treatment repeated twice 14 (17.3%)
Treatment repeated thrice 5 (6.2%)
Infektion)beskriva)att)det)är)i)själva)såret
Other)innebär)att)det)inte)stod)angivet)typ)av)komplikation)
68)komplikationer)hos)59)pat)då)9)pat)fick)infektionx2
Förklara)att)repunch)skedde)hos)65)patienter)med)motsvarande)81)sår)och)totalt)105)repunchar.)
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Discussion  
 
When evaluating the clinical outcome of the punch-graft treatment given by the Department 
of Dermatology at Sahlgrenska University Hospital between January 2004 and September 
2013 by means of this study the results show a healing rate of almost 20 % at 3 months and 50 
% at 12 months. This was slightly less than the results made by Öien et al. having a healing 
rate of 40 % 3 months after pinch-graft (45). The mean time to healing for all ulcers was 
136.2 (±89.6) days with ”other” ulcers having the shortest mean time (about 94 days) 
meanwhile mixed ulcers had the longest time (about 169 days). In the study made by 
Nordström et al. 50 % of the ulcers were healed in a mean time of 76 days (52). An 
explanation to this high rate could be the low number of patients, with only 22 patients 
included in the study. Taking a closer look to the group of diabetic ulcers they also had a high 
healing rate (50% at 12 months). However, the number of ulcers must be taken into 
consideration and this group consisted of only 4 out of 284 ulcers, therefore these results 
cannot be considered trustworthy.  
 
The distribution of ulcer localisation was that leg ulcers being nine times more common than 
the foot ulcers. Venous ulcers dominated and made up for about 40 % of all ulcers followed 
by the mixed ulcers (almost 25 %). Arterial aethiology was not that common, contributing to 
about 11 % of the ulcers. When comparing these results it corresponds with other studies 
showing that venous aethiology is the most common (8, 17). One possible explanation for 
mixed ulcers being this common in our study could be the insecurity when the physician is 
diagnosing the patient. Since many ulcers do not have typical signs of strictly venous or 
arterial disease but instead a mix of both it might be impossible deciding which aethiology is 
the primary cause and the diagnose mixed ulcer is used. Another explanation could be that 
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this type of ulcer is harder to heal compared with other aethiologies and therefore, punch-graft 
is more often used as a treatment for mixed ulcers.  
 
The unequal sex distribution with about 60 % women and 40 % men indicate that more 
women than men are treated with punch-graft. An explanation to this could be that the total 
population suffering from leg ulcers constitutes of more women than men, as showed in 
previous studies (26). This in turn allows us to believe that it has not been any selection 
regarding sex to the punch-graft treatment. Instead it is an average of the total leg ulcer 
population and this correspond with the conclusion that no directives are used when deciding 
who shall receive the punch-graft treatment. Furthermore the age distribution with a mean age 
of 73.2 (±13.6) and approximately 80 % of the punch-grafted population being 65 years or 
older indicates that punch-graft is more common in the elderly population which correspond 
with other studies showing that leg ulcers are most frequent in older people (7). For this study 
it means that probably no selection has been done regarding age and punch-graft treatment, 
instead it is a mean of the total leg ulcer population contributing to the conclusion that there is 
a lack of directives when determine about punch-graft treatment in every single patient case.  
 
When investigating the mean duration of all ulcers at baseline the time was about 25 months 
and as many as almost 70 % of the ulcers had existed for more than 6 months. Further 
investigation of each ulcer type showed that the venous ulcers had the longest mean duration 
with almost 30 months until they were punch-grafted. The remaining ulcer types had almost 
the same mean value with about 20 months until they were punched. Taking this into 
consideration it is possible that ulcers chosen for the punch-graft treatment are the ones which 
have failed to heal during a long time and were most of other options such as conservative 
	   	   	  
	  
29
treatment have shown unsatisfactory results. This could mean that the population treated with 
punch-graft include the most slow-healing ulcers with a poor healing potential from the start 
affecting the punch-graft result. With this in mind we made a statistical analysis investigating 
if there was any correlation between the ulcer duration before the punch-graft treatment and 
the time to healing. However the result was not significant and no conclusions could be made. 
Therefore it might be of interest investigating this relationship, if there is any, further.   
 
Methodological considerations  
One of the findings in this study was the shortage of patient information in some medical 
records making the quantity and quality of the data for each patient a lot varied. Taking this 
into consideration there is a possibility that data regarding healing rate might be inaccurate in 
some subjects reducing the strength of this study’s result. As an example for the sometimes 
parsimonious information in the records the data regarding healing rates at 12 months from 
baseline was found for 87.7 % (249 out of 284) ulcers. One way to avoid this problem could 
be an implementation of directives regarding follow-up for these patients making this work a 
lot easier for all involved in this type of health care.  
 
Almost 30 % of the patients had some kind of complication during the first 3 months. 
However this number is not completely representative since almost all of this data was 
obtained from medical records from the primary care or other health care providers, not 
including Sahlgrenska University Hospital, and many of these records did not arrive to the 
investigator in time. It is hard suggesting a solution to this problem since it is a retrospective 
study depending on the help and participation of other care units providing with their medical 
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records. The ultimate system from a research perspective would be a medical record system 
available for all medical units where access to each valid patient was possible.   
 
Ulcers that was punch-grafted more than once within one year from baseline was about 30 %. 
Remarkably there was no guidelines or criteria to follow when deciding if a new punch-graft 
should be made. In fact, there were no guidelines found for punch-graft at all. Instead it 
seemed like it was up to each physician to decide if and when the treatment should be given.   
This might need to be taken into consideration in the future, making the given health care 
more equal and easier to evaluate.  
 
This study has some weaknesses. Since it is a retrospective case-series study no control-
subjects are included meaning there is nothing to make comparisons with. Therefore the 
conclusions that can be made are limited to a defined population, in this case the punch-
grafted population at the Department of Dermatology at Sahlgrenska during a certain period 
of time. It would be of greater value having a control-group with another treatment method 
for comparison of the outcome and value the effectiveness of punch-graft. The data was 
manually collected meaning there is risks of the human error were data could be missed etc. 
Furthermore data based only on medical charts depends on quality of the content and this has 
varied greatly with some charts including almost all the data and some very few. Another 
weakness is the dependence of charts being sent from the primary care and other health care 
providers, which in this case has not been complete.  
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A possible strength is the number of persons collecting the data. Only 2 persons have been 
involved in this process minimizing the risk of different methods regarding data collection. 
Furthermore there is only one care unit, the Department of Dermatology at Sahlgrenska 
University Hospital that has performed the punch-graft in all these patients hopefully using 
almost the same method. However this can also mean a selection of patients since many of the 
chronic wound ulcer patients are treated in the primary care and therefore not included in a 
study like this. Instead only the more complicated cases are treated at Sahlgrenska University 
Hospital resulting in ulcers that might be harder to heal from the beginning, which might 
result in a lower healing frequency regardless treatment method.  
 
This study does not answer for a complete evaluation of the punch-graft method and therefore 
further research is required. However this study could serve as inspiration for future research.  
The optimal evaluation would be a randomized controlled trial consisting of punch-grafted 
patients in a case-group and patients treated with standard of care or pinch-graft in the 
control-group. 
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Conclusions and Implications  
 
In this study about 20 % of all included ulcers healed within 3 months and 50 % within one 
year after the punch-graft treatment, numbers that are somewhat lower than those in previous 
studies made on pinch-and punch-graft. Furthermore, there was no statistically significant 
evidence showing any correlation between the time of ulcer duration before punch-graft and 
the time to healing. However, ulcers categorized as ”others” had the shortest time to healing, a 
statistically significant result meaning that these might be the most suitable ulcers for 
treatment with punch-graft.  Since this was a case-series study meaning no control-subjects 
were participating it is hard making any conclusions regarding these results. Instead this study 
can serve as groundwork for upcoming research when determining the future of this treatment 
method for hard to heal ulcers.   
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Populärvetenskaplig sammanfattning  
 
Bensår av kronisk karaktär är något som framförallt drabbar den äldre befolkningen och som 
ger upphov till både fysiskt och psykiskt lidande, framförallt är smärta ett stort problem. Med 
tanke på den ökande medellivslängden och det ökande antalet diabetiker finns en risk att även 
antalet bensår ökar framöver. Därför är det av stor vikt att fokusera på behandlingsmetoder för 
detta tillstånd för att kunna undvika onödigt lidande och stoppa utvecklingsprocessen.  
 
På Hudkliniken, Sahlgrenska, har man sedan mitten av 90-talet använt sig av en 
behandlingsmetod för kroniska bensår kallad punchgraft. Denna metod går ut på att man 
flyttar små hudbitar, ca 4mm i diameter, från patientens hud på låret till det aktuella såret. 
Trots denna långvariga användningsperiod på hudkliniken har man inte gjort någon ordentlig 
utredning av behandlingsmetoden och därför kan man inte säga om det verkligen fungerar 
eller inte i jämförelse med andra behandlingsalternativ (såromläggning mm.). Därför 
genomfördes denna studie där fokus var att undersöka hur många sår som hade läkt 3 
respektive 12 månader efter själva punchgraft-behandlingen. Man undersökte även hur länge 
såret hade funnits innan det behandlades samt ifall det fanns något samband mellan hur lång 
tid såret hade funnits innan behandlingen och tiden det tog för såret att läka.  
 
Genom att gå igenom journaler för de patienter som fått denna behandling under januari 2004 
till och med september 2013 kunde ovanstående frågor besvaras. Sammanfattningsvis hade ca 
20 % av alla sår läkt efter 3 månader, ca 50 % efter 12 månader och såren hade i genomsnitt 
funnits i ca 25 månader innan behandlingen. 25 månader är en lång tid och man skulle kunna 
tolka det som att såren man behandlar med punchgraft är de sår som under en lång period har 
behandlats med andra alternativ utan ett tillfredsställande resultat. Dessa sår skulle alltså 
kunna vara svårare att behandla redan från början. Vid undersökning av ett eventuellt 
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samband mellan sårets duration och läkningstiden så kunde inget sådant samband statistiskt 
säkerställas.   
 
Med dessa resultat i handen så har man inte blivit särskilt mycket klokare över behandlingen. 
Istället indikerar denna studie att vidare forskning krävs där man använder sig av ett annat 
tillvägagångssätt för att skaffa sig en tydlig bild av behandlingens effekt och om den har 
bättre resultat i jämförelse med andra behandlingsmetoder. Dock skulle denna studie kunna 
användas som underlag till kommande forskning. Under studiens gång insåg man även att 
riktlinjer för denna behandlingsmetod inte fanns tydligt dokumenterat någonstans samtidigt 
som en stor andel av de anteckningar som var gjorda i patientjournalerna var bristfälliga. En 
lärdom av detta skulle därför vara att nya riktlinjer för metoden krävs för ett konsekvent 
användande av denna tillsammans med förbättrad dokumentation av sjukdomsförlopp osv. för 
att framförallt underlätta för personalen men på sikt även se ett bättre 
patientomhändertagande.  
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	   	   	  
	  
35
Acknowledgements  
	  
I am greatly thankful for all the help and support from my supervisor Henrik Sönnergren 
while writing this master thesis. Furthermore the results would not have been as professional 
as they are without all the good work from Martin Gillstedt with the data collection and the 
statistical analysis. It has also been of great value having the personnel at Intraservice helping 
with patient charts from all the home-nursing units.  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	   	   	  
	  
36
References  
1. Mustoe TA, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current 
treatment strategies: a unifying hypothesis. Plastic and reconstructive surgery. 2006;117(7 
Suppl):35s-41s. 
2. Callam MJ, Ruckley CV, Harper DR, Dale JJ. Chronic ulceration of the leg: extent of the 
problem and provision of care. British medical journal (Clinical research ed). 
1985;290(6485):1855-6. 
3. Cornwall JV, Dore CJ, Lewis JD. Leg ulcers: epidemiology and aetiology. The British 
journal of surgery. 1986;73(9):693-6. 
4. Andersson E, Hansson C, Swanbeck G. Leg and foot ulcers. An epidemiological survey. 
Acta dermato-venereologica. 1984;64(3):227-32. 
5. Lindholm C, Bjellerup M, Christensen OB, Zederfeldt B. A demographic survey of leg and 
foot ulcer patients in a defined population. Acta dermato-venereologica. 1992;72(3):227-30. 
6. Ebbeskog B, Lindholm C, Ohman S. Leg and foot ulcer patients. Epidemiology and 
nursing care in an urban population in south Stockholm, Sweden. Scandinavian journal of 
primary health care. 1996;14(4):238-43. 
7. Douglas WS, Simpson NB. Guidelines for the management of chronic venous leg 
ulceration. Report of a multidisciplinary workshop. British Association of Dermatologists and 
the Research Unit of the Royal College of Physicians. The British journal of dermatology. 
1995;132(3):446-52. 
8. Nelzen O, Bergqvist D, Lindhagen A. Venous and non-venous leg ulcers: clinical history 
and appearance in a population study. The British journal of surgery. 1994;81(2):182-7. 
9. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic 
venous insufficiency in men and women in the general population: Edinburgh Vein Study. 
Journal of epidemiology and community health. 1999;53(3):149-53. 
10. van Korlaar I, Vossen C, Rosendaal F, Cameron L, Bovill E, Kaptein A. Quality of life in 
venous disease. Thrombosis and haemostasis. 2003;90(1):27-35. 
11. Faresjö T KM, Vahlquist C, Elfström J, Leszniewska D, Larsson A. Bensårsbehandling 
dyrare än väntat. Läkartidningen. 1996(14):1355-7. 
12. Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of 
life: financial, social, and psychologic implications. Journal of the American Academy of 
Dermatology. 1994;31(1):49-53. 
	   	   	  
	  
37
13. Hofman D, Ryan TJ, Arnold F, Cherry GW, Lindholm C, Bjellerup M, et al. Pain in 
venous leg ulcers. Journal of wound care. 1997;6(5):222-4. 
14. Hyland M.L, A. Thomason, B. Quality of life of leg ulcer patients: questionnaire and 
preliminary findings. Journal of wound care. 1994;3(6):294-8. 
15. Wollina U, Abdel Naser MB, Hansel G, Helm C, Koch A, Konrad H, et al. Leg ulcers are 
a diagnostic and therapeutic challenge. The international journal of lower extremity wounds. 
2005;4(2):97-104. 
16. Hansson C. Sår och Sårbehandling 2010. T D o Dermathology, Editor 2010, Sahlgrenska 
Universitetssjukhuset: Västra Götalandsregionen. 
17. Callam MJ, Harper DR, Dale JJ, Ruckley CV. Chronic ulcer of the leg: clinical history. 
British medical journal (Clinical research ed). 1987;294(6584):1389-91. 
18. Dale JJ, Callam MJ, Ruckley CV, Harper DR, Berrey PN. Chronic ulcers of the leg: a 
study of prevalence in a Scottish community. Health bulletin. 1983;41(6):310-4. 
19. Valencia IC, Falabella A, Kirsner RS, Eaglstein WH. Chronic venous insufficiency and 
venous leg ulceration. Journal of the American Academy of Dermatology. 2001;44(3):401-21; 
quiz 22-4. 
20. Fowkes FG, Lee AJ, Evans CJ, Allan PL, Bradbury AW, Ruckley CV. Lifestyle risk 
factors for lower limb venous reflux in the general population: Edinburgh Vein Study. 
International journal of epidemiology. 2001;30(4):846-52. 
21. Scott TE, LaMorte WW, Gorin DR, Menzoian JO. Risk factors for chronic venous 
insufficiency: a dual case-control study. Journal of vascular surgery. 1995;22(5):622-8. 
22. Hareendran A, Bradbury A, Budd J, Geroulakos G, Hobbs R, Kenkre J, et al. Measuring 
the impact of venous leg ulcers on quality of life. Journal of wound care. 2005;14(2):53-7. 
23. Gonzalez-Consuegra RV, Verdu J. Quality of life in people with venous leg ulcers: an 
integrative review. Journal of advanced nursing. 2011;67(5):926-44. 
24. Borglund E. Smärtlindring en förutsättning för sårläkning? Läkartidningen. 1988;23:2070. 
25. Nelzén O. Leg Ulcers: Economic Aspects. Phlebology / Venous Forum of the Royal 
Society of Medicine. 2000;15(3-4):110-4. 
26. Callam M. Prevalence of chronic leg ulceration and severe chronic venous disease in 
Western countries. Phlebology / Venous Forum of the Royal Society of Medicine. 1992;7:S6-
S12. 
27. Mekkes JR, Loots MA, Van Der Wal AC, Bos JD. Causes, investigation and treatment of 
leg ulceration. The British journal of dermatology. 2003;148(3):388-401. 
	   	   	  
	  
38
28. Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ. Treating 
the chronic wound: A practical approach to the care of nonhealing wounds and wound care 
dressings. Journal of the American Academy of Dermatology. 2008;58(2):185-206. 
29. Callam MJ, Harper DR, Dale JJ, Ruckley CV. Arterial disease in chronic leg ulceration: 
an underestimated hazard? Lothian and Forth Valley leg ulcer study. British medical journal 
(Clinical research ed). 1987;294(6577):929-31. 
30. Pannier F, Rabe E. Differential diagnosis of leg ulcers. Phlebology / Venous Forum of the 
Royal Society of Medicine. 2013;28 Suppl 1:55-60. 
31. Grey JE, Harding KG, Enoch S. Venous and arterial leg ulcers. BMJ (Clinical research 
ed). 2006;332(7537):347-50. 
32. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. 
Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes care. 
1999;22(3):382-7. 
33. London NJ, Donnelly R. ABC of arterial and venous disease. Ulcerated lower limb. BMJ 
(Clinical research ed). 2000;320(7249):1589-91. 
34. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective 
study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes care. 
1999;22(7):1036-42. 
35. Consensus Development Conference on Diabetic Foot Wound Care. 7-8 April 1999, 
Boston, Massachusetts. American Diabetes Association. Journal of the American Podiatric 
Medical Association. 1999;89(9):475-83. 
36. Reiber G, Boyko E, Smith D. Lower extremity ulcers and amputations in individuals with 
diabetes. . Diabetes in America (2nd edn), Harris MI (ed), National Institute of Health: 
Bethesda. 1995:409-27. 
37. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of 
systemic vasculitides. Proposal of an international consensus conference. Arthritis and 
rheumatism. 1994;37(2):187-92. 
38. Chilvers AS, Freeman GK. Outpatient skin grafting of venous ulcers. Lancet. 
1969;2(7630):1087-8. 
39. Steele K. Pinch grafting for chronic venous leg ulcers in general practice. The Journal of 
the Royal College of General Practitioners. 1985;35(281):574-5. 
40. Oien RF, Hakansson A, Ahnlide I, Bjellerup M, Hansen BU, Borgquist L. Pinch grafting 
in hospital and primary care: a cost analysis. Journal of wound care. 2001;10(5):164-9. 
	   	   	  
	  
39
41. Kirsner RS, Falanga V, Eaglstein WH. The biology of skin grafts. Skin grafts as 
pharmacologic agents. Archives of dermatology. 1993;129(4):481-3. 
42. Norlin K. Hudtransplantation i öppenvård. Läkartidningen. 1987;84:1747-8. 
43. Beckert S, Coerper S, Becker HD. Skin grafting of venous ulcers: a review of its current 
role. The international journal of lower extremity wounds. 2002;1(4):236-41. 
44. Sibbald RG, Williamson D, Orsted HL, Campbell K, Keast D, Krasner D, et al. Preparing 
the wound bed--debridement, bacterial balance, and moisture balance. Ostomy/wound 
management. 2000;46(11):14-22, 4-8, 30-5; quiz 6-7. 
45. Oien RF, Hansen BU, Hakansson A. Pinch grafting of leg ulcers in primary care. Acta 
dermato-venereologica. 1998;78(6):438-9. 
46. Millard LG, Roberts MM, Gatecliffe M. Chronic leg ulcers treated by the pinch graft 
method. The British journal of dermatology. 1977;97(3):289-95. 
47. Christiansen J, Ek L, Tegner E. Pinch grafting of leg ulcers. A retrospective study of 412 
treated ulcers in 146 patients. Acta dermato-venereologica. 1997;77(6):471-3. 
48. Jankunas V, et. a. An analysis of the effectiveness of skin grafting to treat chronic venous 
leg ulcers. Wounds: A Compendium of Clinical Research and Practice. 2007;19(5):128-37. 
49. Warburg FE, Danielsen L, Madsen SM, Raaschou HO, Munkvad S, Jensen R, et al. Vein 
surgery with or without skin grafting versus conservative treatment for leg ulcers. A 
randomized prospective study. Acta dermato-venereologica. 1994;74(4):307-9. 
50. Jones JE, Nelson EA, Al-Hity A. Skin grafting for venous leg ulcers. The Cochrane 
database of systematic reviews. 2013;1:Cd001737. 
51. Helm M. Personal communication by Livia Dunér Holthuis. Registered nurse. Department 
of Dermatology, Sahlgrenska University Hospital. 2014. 
52. Nordstrom A, Hansson C. Punch-grafting to enhance healing and to reduce pain in 
complicated leg and foot ulcers. Acta dermato-venereologica. 2008;88(4):389-91. 
53. Ahnlide I, Bjellerup M. Efficacy of pinch grafting in leg ulcers of different aetiologies. 
Acta dermato-venereologica. 1997;77(2):144-5. 
54. Oien RF, Hakansson A, Hansen BU, Bjellerup M. Pinch grafting of chronic leg ulcers in 
primary care: fourteen years' experience. Acta dermato-venereologica. 2002;82(4):275-8. 
55. World Medical Association Declaration of Helsinki: ethical principles for medical 
research involving human subjects. Jama. 2013;310(20):2191-4. 
 
